

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-drug-cuts-recurrence-risk-by-25-early-stage-breast-cancer-2023-06-02/
https://www.pharmatimes.com/news/eu_regulator_recommends_revoking_approval_for_novartis_sickle_cell_disease_drug_1492209
https://www.pharmtech.com/view/novartis-purchases-cystinosis-gene-therapy-from-avrobio
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-regulator-recommends-revoking-authorisation-novartis-adakveo-2023-05-26/
https://endpts.com/ema-recommends-revoking-authorization-of-novartis-sickle-cell-drug/
https://www.globenewswire.com/news-release/2023/05/25/2675804/0/en/Sandoz-Marketing-Authorization-Applications-for-proposed-biosimilar-denosumab-accepted-by-EMA.html
https://www.fiercepharma.com/pharma/asco-preview-mercks-keytruda-novartis-kisqali-face-moment-truth-early-stage-cancers
https://www.fiercebiotech.com/biotech/novartis-buy-avrobio-gene-therapy-88m-leaving-rest-biotech-shelf
https://endpts.com/novartis-beefs-up-gene-therapy-pipeline-spending-87-5m-on-an-avrobio-therapy/